PRMT5/MEP50 as a critical epigenetic regulator and therapeutic target for therapy-induced neuroendocrine prostate cancer
Research Grant
Administered By
Pathology
Awarded By
Purdue University
Start Date
June 1, 2022
End Date
May 31, 2025
Administered By
Pathology
Awarded By
Purdue University
Start Date
June 1, 2022
End Date
May 31, 2025